FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895962437> ?p ?o ?g. }

• W2895962437 endingPage "310" @default.
• W2895962437 startingPage "293" @default.
• W2895962437 abstract "The repression of renal Farnesoid X Receptor (FXR) had been shown to result from lack of bile acid production from cirrhotic liver. We hypothesized that silymarin and rosuvastatin (Rvs) could have a hepatorenal therapeutic effects in hepatic nephropathy through induction of FXR. Forty two male Wistar rats were used; naïve (n = 12); six of them were sacrificed after 4 weeks and six continued till the end of the experiment. Thirty rats were treated as follows: Rvs, silymarin, thioacetamide (TAA), TAA + Rvs and TAA + silymarin. Liver and kidney function tests as well as the renal and hepatic expression of transforming growth factor β1 (TGFβ1), FXR, dimethylarginine dimethylaminohydrolase-1 (DDAH-1) and eNOS were performed. Histological and immuno-histochemical studies of liver and kidney were also done. TAA-inducted liver cirrhosis was associated with significant deterioration of liver and renal functions together with increasing expression of hepatic and renal TGFβ1 and decreasing expression of hepatic and renal FXR, DDAH-1 and eNOS. Giving silymarin or Rvs induced hepatic and renal improvement which was evidenced biochemically and histologically. Significant positive correlation was detected between all the investigated biomarkers except for the correlation between FXR and TGFβ1 which was negative. In conclusion, liver cirrhosis is associated with deterioration of renal functions. Silymarin and Rvs have a potential hepatorenal therapeutic benefit through simultaneous enhancement of FXR/DDAH-1/eNOS pathway in both organs." @default.
• W2895962437 created "2018-10-26" @default.
• W2895962437 creator A5057959519 @default.
• W2895962437 creator A5064080114 @default.
• W2895962437 creator A5070801896 @default.
• W2895962437 creator A5080528687 @default.
• W2895962437 creator A5091283364 @default.
• W2895962437 date "2018-12-01" @default.
• W2895962437 modified "2023-10-04" @default.
• W2895962437 title "Insights into hepatic and renal FXR/DDAH-1/eNOS pathway and its role in the potential benefit of rosuvastatin and silymarin in hepatic nephropathy" @default.
• W2895962437 cites W1969047205 @default.
• W2895962437 cites W1977694654 @default.
• W2895962437 cites W1980312274 @default.
• W2895962437 cites W1994223673 @default.
• W2895962437 cites W1994901730 @default.
• W2895962437 cites W1996934048 @default.
• W2895962437 cites W2016257140 @default.
• W2895962437 cites W2017705141 @default.
• W2895962437 cites W2023503151 @default.
• W2895962437 cites W2023848963 @default.
• W2895962437 cites W2024912918 @default.
• W2895962437 cites W2030085966 @default.
• W2895962437 cites W2036510508 @default.
• W2895962437 cites W2037420560 @default.
• W2895962437 cites W2043331312 @default.
• W2895962437 cites W2049025963 @default.
• W2895962437 cites W2050816734 @default.
• W2895962437 cites W2053651328 @default.
• W2895962437 cites W2064606484 @default.
• W2895962437 cites W2064662214 @default.
• W2895962437 cites W2075724482 @default.
• W2895962437 cites W2078018989 @default.
• W2895962437 cites W2089050591 @default.
• W2895962437 cites W2090170448 @default.
• W2895962437 cites W2095177675 @default.
• W2895962437 cites W2100162678 @default.
• W2895962437 cites W2101568779 @default.
• W2895962437 cites W2115955912 @default.
• W2895962437 cites W2122678100 @default.
• W2895962437 cites W2124728251 @default.
• W2895962437 cites W2126903895 @default.
• W2895962437 cites W2131086332 @default.
• W2895962437 cites W2133996615 @default.
• W2895962437 cites W2136808905 @default.
• W2895962437 cites W2139797791 @default.
• W2895962437 cites W2142811977 @default.
• W2895962437 cites W2144417775 @default.
• W2895962437 cites W2163724042 @default.
• W2895962437 cites W2317298663 @default.
• W2895962437 cites W2467719865 @default.
• W2895962437 cites W2524940154 @default.
• W2895962437 cites W2560713446 @default.
• W2895962437 cites W2580084393 @default.
• W2895962437 cites W2766093969 @default.
• W2895962437 cites W2792830953 @default.
• W2895962437 doi "https://doi.org/10.1016/j.yexmp.2018.10.004" @default.
• W2895962437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30308196" @default.
• W2895962437 hasPublicationYear "2018" @default.
• W2895962437 type Work @default.
• W2895962437 sameAs 2895962437 @default.
• W2895962437 citedByCount "4" @default.
• W2895962437 countsByYear W28959624372018 @default.
• W2895962437 countsByYear W28959624372019 @default.
• W2895962437 countsByYear W28959624372022 @default.
• W2895962437 crossrefType "journal-article" @default.
• W2895962437 hasAuthorship W2895962437A5057959519 @default.
• W2895962437 hasAuthorship W2895962437A5064080114 @default.
• W2895962437 hasAuthorship W2895962437A5070801896 @default.
• W2895962437 hasAuthorship W2895962437A5080528687 @default.
• W2895962437 hasAuthorship W2895962437A5091283364 @default.
• W2895962437 hasConcept C104317684 @default.
• W2895962437 hasConcept C126322002 @default.
• W2895962437 hasConcept C134018914 @default.
• W2895962437 hasConcept C159641895 @default.
• W2895962437 hasConcept C203862802 @default.
• W2895962437 hasConcept C2776988256 @default.
• W2895962437 hasConcept C2777214474 @default.
• W2895962437 hasConcept C2777622882 @default.
• W2895962437 hasConcept C2778326061 @default.
• W2895962437 hasConcept C2780091579 @default.
• W2895962437 hasConcept C2781057625 @default.
• W2895962437 hasConcept C519581460 @default.
• W2895962437 hasConcept C55493867 @default.
• W2895962437 hasConcept C63932345 @default.
• W2895962437 hasConcept C71924100 @default.
• W2895962437 hasConcept C86339819 @default.
• W2895962437 hasConcept C86803240 @default.
• W2895962437 hasConcept C90924648 @default.
• W2895962437 hasConceptScore W2895962437C104317684 @default.
• W2895962437 hasConceptScore W2895962437C126322002 @default.
• W2895962437 hasConceptScore W2895962437C134018914 @default.
• W2895962437 hasConceptScore W2895962437C159641895 @default.
• W2895962437 hasConceptScore W2895962437C203862802 @default.
• W2895962437 hasConceptScore W2895962437C2776988256 @default.
• W2895962437 hasConceptScore W2895962437C2777214474 @default.
• W2895962437 hasConceptScore W2895962437C2777622882 @default.
• W2895962437 hasConceptScore W2895962437C2778326061 @default.
• W2895962437 hasConceptScore W2895962437C2780091579 @default.

• next